Search Result "polypharmacy and valproic acid"
Polypharmacy- Purpose, Benefits and Limitations
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 35 Year: 2022 Page: 5606-5614
Author(s):
Polypharmacy in Psychiatry: An In-depth Examination of Drug-drugInteractions and Treatment Challenges
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 21 Year: 2024 Page: 1641-1649
Author(s):
Antiepileptic Drugs (AEDs) Polypharmacy Could Lead to Buried Pharmacokinetic Interactions due to CYP450
Journal: Drug Metabolism Letters
Volume: 6 Issue: 3 Year: 2012 Page: 207-212
Author(s): Z. Tolou-Ghamari
Antiepileptic Drugs During Pregnancy: Pharmacokinetics and Transplacental Transfer
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 5 Year: 2011 Page: 781-788
Author(s): Marco De Santis, Carmen De Luca, Ilenia Mappa, Elena Cesari, Tomasella Quattrocchi, Terryann Spagnuolo, Daniela Visconti, Alessandro Caruso
Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
Journal: Current Drug Metabolism
Volume: 18 Issue: 8 Year: 2017 Page: 735-756
Author(s): Roberto Mandrioli,Laura Mercolini
Drug-Induced Anemia and Other Red Cell Disorders: A Guide in the Age of Polypharmacy
Journal: Current Clinical Pharmacology
Volume: 6 Issue: 4 Year: 2011 Page: 295-303
Author(s): Aryeh Shander, Mazyar Javidroozi, > E. Ashton
Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Journal: Current Vascular Pharmacology
Volume: 6 Issue: 4 Year: 2008 Page: 271-281
Author(s): Minako Yamaoka-Tojo, Taiki Tojo, Tohru Izumi
Antihypertensive Drug Interactions
Ebook: Current and Future Developments in Hypertension
Volume: 1 Year: 2019
Author(s): Cigdem Usul Afsar,Sibel Ozyazgan
Doi: 10.2174/9789811422720119010006
Adverse Drug Reactions: Trends in a Tertiary Care Hospital
Journal: Current Drug Safety
Volume: 7 Issue: 5 Year: 2012 Page: 384-388
Author(s): Harmeet S. Rehan,Deepti Chopra,Ravinder K. Sah,Ritu Mishra
Metabolic Syndrome in Schizophrenia: Focus on the Role of Antipsychotic Medications and Indications for Therapeutic Drug Monitoring (TDM) Methods
Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 5 Year: 2020
Author(s): Roberto Mandrioli,Michele Protti,Laura Mercolini
Doi: 10.2174/9781681087535120050003